Treatment with the BRD4 inhibitor JQ1 significantly suppresses super-enhancer-associated ETV6 gene expression and induces nasopharyngeal carcinoma cell growth inhibition [37] (Table 1). This evidence concerns the gene BRD4 and nasopharyngeal carcinoma.